Why Perinatal HPP Survivability Is Critical: Important Respiratory Support and Next Steps

Hypophosphatasia (HPP) is a rare inherited disorder caused by deficient activity of the enzyme alkaline phosphatase. The perinatal form is the most severe and often life-threatening. Understanding why early survivability matters—and how to optimize respiratory support and next steps—can help families and care teams navigate this challenging diagnosis.

What Is Perinatal Hypophosphatasia?

• Genetic basis: Mutations in the ALPL gene reduce tissue-nonspecific alkaline phosphatase (TNSALP) activity.
• Deposit problems: Low enzyme activity causes poor bone mineralization and defects in lung development.
• Early onset: Signs can appear in utero or at birth, with severe skeletal deformities and respiratory distress.

Hypophosphatasia Life Expectancy, Perinatal Form

• Historically, perinatal HPP was almost universally fatal within hours to days.
• With modern interventions (especially enzyme replacement therapy), some infants now survive beyond the newborn period.
• Survivors often require lifelong multidisciplinary care; long-term life expectancy data are evolving as treatments improve.

Why Early Survivability Is Critical

1. Respiratory Function Depends on Early Intervention

   • Under-mineralized ribs and chest wall lead to restrictive lung disease.
   • Without prompt support, respiratory failure is common.

2. Timing of Enzyme Replacement Therapy (ERT)

   • Asfotase alfa (the only approved ERT for HPP) is most effective when started early.
   • Early ERT can improve bone mineralization, chest wall mechanics, and overall survival.

3. Preventing Long-Term Complications

   • Surviving the neonatal period allows time to address issues like seizures, low muscle tone, and feeding difficulties.
   • Early physical and occupational therapy can support motor development.

Key Respiratory Support Strategies

Non-Invasive Ventilation (NIV)

• Types: Nasal continuous positive airway pressure (nCPAP) or bilevel positive airway pressure (BiPAP).
• Benefits:
  • Improves oxygenation without intubation.
  • Allows feeding by mouth or via feeding tube.
• Considerations:
  • Requires close monitoring for nasal trauma and facial pressure sores.
  • Experienced respiratory therapists and neonatal ICU (NICU) staff are essential.

Mechanical Ventilation

• When it’s used:
  • If NIV fails to maintain adequate oxygen and carbon dioxide levels.
  • During critical periods such as post-operative care for skeletal interventions.
• Challenges:
  • Risk of ventilator-associated lung injury.
  • Weaning can be prolonged due to chest wall rigidity.

High-Frequency Oscillatory Ventilation (HFOV)

• Purpose:
  • Provides very small tidal volumes at high rates.
  • Minimizes barotrauma in fragile lungs.
• Application:
  • Often a bridge when conventional ventilation is inadequate.
  • Requires a specialized team familiar with neonatal HFOV.

Extracorporeal Membrane Oxygenation (ECMO)

• Use:
  • Rarely, as a last resort when all other support fails.
  • Provides cardiac and respiratory support by oxygenating blood outside the body.
• Risks:
  • Bleeding, infection, and technical complications.
  • Typically limited to centers with ECMO expertise.

Enzyme Replacement Therapy (Asfotase Alfa)

• Mechanism: Replaces deficient alkaline phosphatase to promote bone mineralization.
• Administration: Subcutaneous injections, often daily or multiple times per week.
• Impacts on Respiratory Health:
  • Gradual chest wall strengthening.
  • Improved lung expansion and reduced ventilator dependence.
• Monitoring:
  • Regular X-rays to track bone mineral density.
  • Laboratory tests for calcium, phosphate, and alkaline phosphatase levels.
• Side Effects:
  • Injection-site reactions.
  • Potential for antibody development, though serious immune reactions are rare.

Multidisciplinary Care Team

Survivability and long-term outcomes hinge on coordination among:

• Neonatologists and Pediatric Pulmonologists
  Manage respiratory support, ventilator weaning, and infection prevention.

• Geneticists and Metabolic Specialists
  Confirm diagnosis, counsel families, and guide genetic testing for siblings or future pregnancies.

• Orthopedists and Physical Therapists
  Address skeletal deformities, improve mobility, and prevent contractures.

• Nutritionists and Feeding Specialists
  Ensure adequate growth and caloric intake, often via gastrostomy tube.

• Social Workers and Psychologists
  Provide emotional support, connect families with resources, and aid in long-term care planning.

Next Steps After Initial Stabilization

1. Confirm and Document Diagnosis

   • Genetic testing to identify ALPL mutations.
   • Baseline bone density and chest imaging.

2. Start or Optimize Enzyme Replacement Therapy

   • Initiate as soon as medical stability allows.
   • Adjust dosing based on growth, enzyme levels, and radiologic findings.

3. Develop a Respiratory Weaning Plan

   • Set realistic goals for reducing ventilator settings.
   • Incorporate regular trials off support under close supervision.

4. Plan for Home Care

   • Train caregivers in ventilator management and emergency procedures.
   • Arrange for durable medical equipment (DME), oxygen supplies, and home nursing if needed.

5. Regular Follow-Up and Monitoring

   • Frequent clinic visits to assess growth, lung function, and bone health.
   • Pulmonary function tests (PFTs) as age-appropriate.
   • Imaging studies every 6–12 months to track skeletal development.

6. Evaluate for Clinical Trials and Emerging Therapies

   • New gene therapies and small-molecule drugs are under investigation.
   • Participation may offer access to cutting-edge treatments but should be weighed carefully.

Coping and Family Support

• Education: Learn as much as possible about perinatal HPP.
• Support Groups: Connect with other families through nonprofit foundations.
• Mental Health: Counseling can help process grief, stress, and caregiver fatigue.
• Financial Planning: Work with social services to access insurance benefits and community resources.

Using the Ubie Symptom Checker

If you or a family member experience new or worsening symptoms—such as increased work of breathing or unusual bone pain—you might consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker. It can help you decide whether to seek urgent medical attention or schedule a specialist visit.
Free, online symptom check, using the doctor approved Ubie Symptom Checker

Final Thoughts and Urgent Advice

Perinatal HPP remains a serious condition, but with early respiratory support, enzyme replacement therapy, and coordinated care, long-term survivability and quality of life have improved. Close monitoring, proactive planning, and strong support networks are essential.

If you notice any life-threatening signs—such as severe breathing difficulty, sudden changes in consciousness, or unrelenting pain—please speak to a doctor immediately. Regular follow-up with your medical team is crucial for the best outcomes.